• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Meridian Bioscience, Inc. (VIVO)

    -NasdaqGS
    16.68 Down 0.02(0.12%) Dec 24, 1:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:18.00
    Median Target:18.50
    High Target:20.00
    Low Target:15.00
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 6, 2014Robert W. BairdDowngradeOutperformNeutral
    Jul 27, 2012Canaccord GenuityDowngradeBuyHold
    Apr 25, 2011WedbushUpgradeUnderperformNeutral
    Mar 24, 2011Canaccord GenuityUpgradeHoldBuy
    Nov 16, 2010Canaccord GenuityInitiated Hold
    Apr 7, 2010WedbushInitiated Underperform
    Mar 6, 2009William BlairInitiated Mkt Perform
    Oct 14, 2008Lazard CapitalInitiated Buy
    Jul 21, 2008Hilliard LyonsUpgradeNeutralLong-term Buy
    May 14, 2008Susquehanna FinancialInitiated Neutral

    More Upgrades & Downgrades for VIVO

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0011
    Buy1111
    Hold7778
    Underperform1111
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.